Molecular Therapy: Methods & Clinical Development (Dec 2017)

Profiling the Targets of Protective CD8+ T Cell Responses to Infection

  • Joseph T. Bruder,
  • Ping Chen,
  • Greg Ekberg,
  • Emily C. Smith,
  • Christopher A. Lazarski,
  • Bennett A. Myers,
  • Jessica Bolton,
  • Martha Sedegah,
  • Eileen Villasante,
  • Thomas L. Richie,
  • C. Richter King,
  • Joao C. Aguiar,
  • Denise L. Doolan,
  • Douglas E. Brough

DOI
https://doi.org/10.1016/j.omtm.2017.08.003
Journal volume & issue
Vol. 7, no. C
pp. 20 – 31

Abstract

Read online

T cells are critical effectors of host immunity that target intracellular pathogens, such as the causative agents of HIV, tuberculosis, and malaria. The development of vaccines that induce effective cell-mediated immunity against such pathogens has proved challenging; for tuberculosis and malaria, many of the antigens targeted by protective T cells are not known. Here, we report a novel approach for screening large numbers of antigens as potential targets of T cells. Malaria provides an excellent model to test this antigen discovery platform because T cells are critical mediators of protection following immunization with live sporozoite vaccines and the specific antigen targets are unknown. We generated an adenovirus array by cloning 312 highly expressed pre-erythrocytic Plasmodium yoelii antigens into adenovirus vectors using high-throughput methodologies. The array was screened to identify antigen-specific CD8+ T cells induced by a live sporozoite vaccine regimen known to provide high levels of sterile protection mediated by CD8+ T cells. We identified 69 antigens that were targeted by CD8+ T cells induced by this vaccine regimen. The antigen that recalled the highest frequency of CD8+ T cells, PY02605, induced protective responses in mice, demonstrating proof of principle for this approach in identifying antigens for vaccine development.

Keywords